Trade Summary

6 days ago, Boughton Soleil, serving as GC at Hims & Hers Health, Inc. (HIMS), sold 4,812 shares at $24.69 per share, for a total transaction value of $118,808.00. Following this transaction, Boughton Soleil now holds 308,831 shares of HIMS.

This sale represents a 2.00% decrease in Boughton Soleil's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, March 17, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 1 day after the trade was made.

Hims & Hers Health, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.